FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease

The U.S. Food and Drug Administration cleared the first blood test, which measures two key biomarkers, to aid in diagnosing Alzheimer’s disease in people exhibiting symptoms of the disease.
Source: FDA Press Releases

Leave a Comment





This site uses Akismet to reduce spam. Learn how your comment data is processed.